openPR Logo
Press release

Interferons Global Market is Booming Across the Globe and Witness Huge Growth By Key Players To 2033 | The Business Research Company

04-25-2024 10:24 AM CET | Health & Medicine

Press release from: The Business research company

Interferons Global Market

Interferons Global Market

The interferons market size has grown steadily in recent years. It will grow from $9.17 billion in 2023 to $9.54 billion in 2024 at a compound annual growth rate (CAGR) of 4.0%. The growth in the historic period can be attributed to viral infections, antiviral therapies, cancer treatment, autoimmune diseases.

The interferons market size is expected to see steadily grown in the next few years. It will grow to $11.98 billion in 2028 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to immunotherapy advancements, precision medicine, viral outbreak preparedness, drug combinations, gene therapy. Major trends in the forecast period include expanding applications, biopharmaceutical innovation, interferon combinations, personalized medicine.

Market Overview -
Interferons refer to a natural substance that supports the body's immune system in the battle against illness, including cancer. White blood cells and other cells in the body produce interferons, but they can also be produced in a lab for use in treating various disorders.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=2836&type=smp

Elevated Incidence Of Cancer Propels Growth In The Interferon Market
The rise in cancer is expected to boost the growth of the interferon market going forward. Cancer is a group of diseases characterized by the development of abnormal cells that divide uncontrollably and have the ability to spread to other parts of the body. Interferons are used in the treatment of various types of cancer, including melanoma, Kaposi's sarcoma, and certain leukemias. They are often included in combination therapies, helping to boost the body's immune response against cancer cells. For instance, in January 2022, according to a report published by the American Cancer Society, a US-based health organization, in the US, 609,360 cancer deaths and 1.9 million new cancer cases are anticipated in 2022. There are expected to be 10,470 pediatric cancer cases in 2022. Additionally, 5,480 teenagers are anticipated to have cancer diagnoses in 2022. Therefore, the rise in cancer is driving the growth of the interferon market.

Competitive Landscape -
Major companies operating in the interferons market include Roche Holding AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Biogen Inc., Bayer AG, Zydus Cadila Health Care Limited, Novartis AG, Pfizer Inc., Biosidus S.A., Nanogen Biopharmaceutical Co. Ltd., Amega Biotech Inc., Rhein Minapharm Biogenetics S.A.E., PROBIOMED S.A. de C.V., Schering-Plough Corporation, 3SBio Inc., AbbVie Inc., Celgene Corporation, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Genentech Inc., GlaxoSmithKline plc, Johnson & Johnson, Novo Nordisk A/S, Sanofi S.A., Shire plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Biocad, Cipla Limited, Dr. Reddy's Laboratories Ltd., Hetero Drugs Limited

Rising Adoption Of Interferon Biosimilars
Biologics therapy is expensive and it places a substantial financial burden on the healthcare system. The increasing prevalence of diseases such as hepatitis, MS, and cancers in the world presented an opportunity to evaluate the clinical applications of biosimilars and has stimulated some of the local pharmaceutical companies to produce interferon biosimilar medications to compete (or replace) the original expensive brands. IFNs were initially investigated for their potential as antivirals, however, they are now commonly used in anti-HBV (hepatitis B virus) and anti-HCV (hepatitis C virus) therapy. The therapeutic potential of interferon biosimilars for hepatitis and cancer, coupled with the ongoing studies on interferon biosimilars to have prophylactic or therapeutic effectiveness in SARS (severe acute respiratory syndrome), influenza, or another virus pandemic, is contributing to the increasing adoption of interferon biosimilars over expensive biologics.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/interferon-global-market-report

Key Segments -
The interferons market covered in this report is segmented -
1) By Type: Inteferon Alpha, Inteferon Beta, Inteferon Gamma
2) By Application: Hepatitis B, Hepatitis C, Melanoma, Leukemia, Multiple Sclerosis, Renal Cell Carcinoma
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Other Distribution Channels

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Interferons Global Market is Booming Across the Globe and Witness Huge Growth By Key Players To 2033 | The Business Research Company here

News-ID: 3476136 • Views:

More Releases from The Business research company

Leading Companies Fueling Growth and Innovation in the Radiofaxes Market
Leading Companies Fueling Growth and Innovation in the Radiofaxes Market
The radiofaxes market is poised for notable expansion as advancements in communication technology continue to evolve. This sector plays a critical role in delivering weather and navigation data across remote and maritime environments, and with ongoing innovations, it is set to reach new heights by 2030. Let's explore the market's size, key drivers, leading companies, and segmentation to better understand its future trajectory. Expected Market Size and Growth Outlook for the
In-Depth Examination of Segments, Industry Trends, and Key Players in the Radar Sensor Market
In-Depth Examination of Segments, Industry Trends, and Key Players in the Radar …
The radar sensor market is on the brink of substantial expansion, driven by rapid technological advancements and growing applications across various industries. As radar sensors become more integrated with cutting-edge technologies like artificial intelligence and machine learning, their relevance and demand continue to surge. Below, we explore the current market valuation, leading players, key trends, and the segmentation that defines this evolving sector. Anticipated Growth and Market Size of the Radar
Top Companies and Industry Competition in the Private Jet Charter Services Market
Top Companies and Industry Competition in the Private Jet Charter Services Marke …
The private jet charter services market is on a trajectory of significant expansion, fueled by evolving consumer preferences and technological innovations. With luxury travel gaining popularity and new digital solutions simplifying bookings, this sector is set to undergo remarkable changes in the coming years. Let's explore the market's projected growth, key players, emerging trends, and important segments shaping its future. Projected Expansion and Market Size of Private Jet Charter Services The
Overview of Segmentation, Market Trends, and Competitive Landscape in the Plasma Rocket Propulsion Market
Overview of Segmentation, Market Trends, and Competitive Landscape in the Plasma …
The plasma rocket propulsion market is gaining significant traction as space exploration and satellite deployment continue to advance rapidly. Innovations in propulsion technologies are driving new possibilities for long-duration missions and efficient satellite maneuvering. Below, we explore the market's projected growth, key players, emerging trends, and the main segments shaping this dynamic industry. Projected Expansion and Market Size for Plasma Rocket Propulsion The plasma rocket propulsion market is poised for substantial

All 5 Releases


More Releases for Interferon

Interferon Beta Drugs Market Size, Opportunities 2022-2030
The global Interferon Beta Drugs Market is witnessing significant growth, driven by rising incidences of multiple sclerosis and increasing advancements in biologics. As we approach 2030, the market is poised for substantial expansion, fueled by the growing demand for effective treatments and the introduction of innovative therapies. This press release provides a comprehensive overview of the Interferon Beta Drugs Market, highlighting key trends, growth drivers, market restraints, competitive landscape, and
Interferon Beta Drugs Market Size, Opportunities 2023-2032
In the realm of pharmaceuticals, Interferon Beta Drugs have emerged as a promising avenue in the treatment of various diseases, particularly autoimmune disorders like multiple sclerosis (MS). This class of drugs has garnered significant attention for its immunomodulatory properties and potential therapeutic benefits. As the healthcare landscape continues to evolve, understanding the Interferon Beta Drugs market becomes pivotal for stakeholders aiming to capitalize on emerging opportunities and navigate through challenges
Interferon Biosimilar Market to Witness Robust Expansion by 2031
The Interferon Biosimilar Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). The advent of novel drug delivery and combination therapies is one of the critical reasons that will drive the interferon market's growth. The administration of these through the intravenous RoA increases the risks of extravasation and causes side-effects such as swelling, redness, and irritation at the injection site. As
Recombinant Human Interferon a1b Market 2021 | Detailed Report
Recombinant Human Interferon a1b Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027. Get Free Sample PDF (including full TOC, Tables and Figures) of Recombinant Human Interferon a1b Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4524711 The report provides a comprehensive analysis of company profiles listed below: - Beijing Tri-Prime
Interferon Market to Foresee Remarkable Expansion by 2026
(United States, Portland ): Big Market Research newly added a research report on the Interferon Market which represents a study for the period from 2021 to 2026. The research study provides a near look at the market scenario and dynamics impacting its growth. This report highlights the crucial developments along with other events happening in the market which are marking on the growth and opening doors for future growth in the
Natural Interferon (IFN) Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Natural Interferon (IFN) Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 124 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-natural-interferon-ifn-market_p104022.html   Interferon (IFN) referred to as a